/C O R R E C T I O N -- Coventry/
Coventry First LLC and its Executive Chairman Alan H. Buerger have filed a Motion to Dismiss a lawsuit brought by Abacus Global Management (NASDAQ: ABL) in the U.S. District Court for the Middle District of Florida. The motion, filed on September 2, 2025, argues that Abacus's lawsuit attempts to suppress constitutionally protected debate.
A key development supporting Coventry's position is that Lapetus Solutions, Abacus's primary life expectancy provider, ceased operations on August 31, 2025. Buerger emphasizes that transparent discussion about life expectancy estimates and industry practices is crucial for investors, regulators, and the overall life settlement market.
Coventry First LLC e il suo Presidente Esecutivo Alan H. Buerger hanno presentato una mozione di respingimento riguardo a una causa intentata da Abacus Global Management (NASDAQ: ABL) presso la Corte Distrettuale degli Stati Uniti per il Middle District della Florida. La mozione, depositata il 2 settembre 2025, sostiene che la causa di Abacus cerchi di sopprimere un dibattito protetto costituzionalmente.
Un elemento chiave a sostegno della posizione di Coventry 猫 che Lapetus Solutions, il principale fornitore di stime di aspettativa di vita di Abacus, ha cessato le attivit脿 il 31 agosto 2025. Buerger sottolinea che un confronto trasparente sulle stime di aspettativa di vita e sulle pratiche del settore 猫 fondamentale per investitori, regolatori e per il mercato complessivo delle life settlement.
Coventry First LLC y su presidente ejecutivo Alan H. Buerger han presentado una moci贸n para desestimar una demanda interpuesta por Abacus Global Management (NASDAQ: ABL) en el Tribunal de Distrito de los Estados Unidos para el Distrito Medio de Florida. La moci贸n, presentada el 2 de septiembre de 2025, argumenta que la demanda de Abacus pretende suprimir un debate protegido constitucionalmente.
Un hecho relevante que respalda la posici贸n de Coventry es que Lapetus Solutions, el principal proveedor de estimaciones de esperanza de vida de Abacus, ces贸 sus operaciones el 31 de agosto de 2025. Buerger enfatiza que el debate transparente sobre las estimaciones de esperanza de vida y las pr谩cticas del sector es crucial para inversores, reguladores y el mercado de life settlements en general.
Coventry First LLC鞕� 攴� 齑濌磩 須岇灔 Alan H. Buerger电� Abacus Global Management (NASDAQ: ABL)臧赌 頂岆毽嫟 欷戨秬 歆�氚� 鞐半癌歆�氚╇矔鞗愳棎 鞝滉赴頃� 靻岇啞鞚� 旮瓣皝頃� 雼澕电� 霃欖潣鞁犾箔鞚� 鞝滌稖頄堨姷雼堧嫟. 鞚� 霃欖潣鞁犾箔鞚� 2025雲� 9鞗� 2鞚� 鞝滌稖霅橃棃鞙茧┌, Abacus鞚� 靻岇啞鞚� 項岆矔鞝侅溂搿� 氤错樃霅樀鐢 韱犽鞚� 鞏奠晻頃橂牑 頃滊嫟瓿� 欤检灔頃╇媹雼�.
Coventry鞚� 鞛呾灔鞚� 霋冯皼旃晿电� 欤检殧 靷嫟鞚� Abacus鞚� 欤检殧 旮半寑靾橂獏 鞝滉车鞐呾泊鞚� Lapetus Solutions臧赌 2025雲� 8鞗� 31鞚�鞛愲 鞖挫榿鞚� 欷戨嫧頄堧嫟电� 鞝愳瀰雼堧嫟. Buerger电� 旮半寑靾橂獏 於旍爼旃橃檧 鞐呹硠 甏�頄夓棎 雽�頃� 韴獏頃� 雲检潣臧赌 韴瀽鞛�, 攴滌牅雼龟淡 氚� 鞝勳泊 靸濍獏氤错棙鞝曥偘(life settlement) 鞁滌灔鞐� 欷戩殧頃橂嫟瓿� 臧曥“頃╇媹雼�.
Coventry First LLC et son pr茅sident ex茅cutif Alan H. Buerger ont d茅pos茅 une requ锚te en rejet d鈥檜ne action intent茅e par Abacus Global Management (NASDAQ: ABL) devant le tribunal f茅d茅ral des 脡tats-Unis pour le Middle District de Floride. La requ锚te, d茅pos茅e le 2 septembre 2025, soutient que la plainte d鈥橝bacus cherche 脿 r茅primer un d茅bat prot茅g茅 par la Constitution.
Un d茅veloppement cl茅 appuyant la position de Coventry est que Lapetus Solutions, le principal fournisseur d鈥檈stimations d鈥檈sp茅rance de vie d鈥橝bacus, a cess茅 ses activit茅s le 31 ao没t 2025. Buerger souligne que des discussions transparentes sur les estimations d鈥檈sp茅rance de vie et les pratiques du secteur sont cruciales pour les investisseurs, les r茅gulateurs et le march茅 des life settlements dans son ensemble.
Coventry First LLC und dessen Executive Chairman Alan H. Buerger haben einen Antrag auf Abweisung einer Klage eingereicht, die Abacus Global Management (NASDAQ: ABL) beim US-Bezirksgericht f眉r den Middle District of Florida eingereicht hatte. Der am 2. September 2025 eingereichte Antrag f眉hrt aus, dass Abacus鈥� Klage versucht, verfassungsrechtlich gesch眉tzte Debatten zu unterdr眉cken.
Ein wesentlicher Aspekt, der Coventrys Position st眉tzt, ist, dass Lapetus Solutions, Abacus鈥� Hauptanbieter f眉r Lebenserwartungsprognosen, den Betrieb am 31. August 2025 eingestellt hat. Buerger betont, dass eine transparente Auseinandersetzung 眉ber Lebenserwartungssch盲tzungen und Branchenpraktiken f眉r Investoren, Aufsichtsbeh枚rden und den gesamten Life-Settlement-Markt von zentraler Bedeutung ist.
- Motion to Dismiss highlights First Amendment protection for industry debate
- Development regarding Lapetus shutdown supports Coventry's position
- Legal dispute could create uncertainty for stakeholders
- Shutdown of Lapetus Solutions affects Abacus's life expectancy assessment capabilities
In the news release, Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit, issued 02-Sep-2025 by Coventry over PR Newswire, we are advised by the company that the first paragraph, last sentence, should read "The full Motion to Dismiss" rather than "The full Complaint" as originally issued. The complete, corrected release follows:
Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit
Motion underscores that Abacus's claims lack merit as Lapetus, its key life expectancy provider, shut its doors August 31
In the filing, Coventry and Mr. Buerger express their view that Abacus's lawsuit is an effort to silence constitutionally protected debate. As the Motion states:
"The First Amendment expresses 'a profound national commitment to the principle that debate on public issues should be uninhibited, robust, and wide-open.' Abacus, however, seeks to flip that principle on its head. Faced with criticism about serious problems of its own making, Abacus brought this meritless lawsuit to muzzle those who have highlighted the truth or expressed their constitutionally protected opinions. That it cannot do."
The Motion also highlights that Abacus invested in and relied heavily upon Lapetus Solutions, Inc. ("Lapetus") as its primary life expectancy provider 鈥� but Lapetus publicly announced that it shut down all operations effective August 31, 2025. This development underscores the concerns raised regarding Abacus's practices and the importance of open debate about the life settlement industry.聽
"Abacus's complaint is an attempt to silence robust debate on important issues affecting the life settlement industry, including the reliability of life expectancy estimates," said Mr. Buerger. "Transparent disclosures advance the interests of investors, regulators, and the life settlement market as a whole, and the First Amendment protects the right to voice opinions and concerns, particularly on matters of such public interest."
About Coventry
Coventry is the leader and creator of the secondary market for life insurance. For more than 20 years, we have been driving the industry forward and expanding opportunities for life insurance policyowners. Coventry's deep experience combined with a fierce commitment to consumer rights makes Coventry the clear market leader, a position we use to raise industry standards and expand consumer choice. To date, we have delivered more than
Media Contacts:
Prosek Partners for Coventry
Andy Merrill / Kiki Tarkhan
笔谤辞-颁辞惫别苍迟谤测蔼辫谤辞蝉别办.肠辞尘听
View original content:
SOURCE Coventry
FAQ
What is the lawsuit between Coventry First and Abacus Global Management (NASDAQ: ABL) about?
Why did Coventry file a Motion to Dismiss against Abacus's lawsuit?
What happened to Lapetus Solutions and how does it affect Abacus (ABL)?
How does the First Amendment relate to Coventry's Motion to Dismiss against Abacus?
What are the implications of this legal dispute for the life settlement industry?
